康众医疗推进股票期权激励计划,增资AI医疗影像公司

Group 1: Core Insights - The company is advancing a stock option incentive plan and increasing investment in AI medical imaging company, Mind Intelligence [1][3] - The stock option incentive plan aims to motivate the core team, with details on grant conditions and exercise arrangements expected to be a focus [2] - The company has announced a projected net profit loss for 2025, estimated between 5 million to 9 million, with a non-recurring net profit loss expected between 12 million to 18 million [4] Group 2: Project Developments - The company plans to invest 70 million yuan in Mind Intelligence, acquiring a 7.3684% stake, to enter the AI medical imaging sector [3] - The integration of business operations, technological collaboration, and performance contributions from this investment are anticipated to gradually materialize in the future [3]

CareRay-康众医疗推进股票期权激励计划,增资AI医疗影像公司 - Reportify